SR One
SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. With a transatlantic presence, SR One focuses on companies with strong fundamentals and novel approaches to addressing diseases, aiming to reimagine today's science for tomorrow's medicines.
SR One
929 Main Street, Suite 200, Redwood City, CA 94063, United States
Portfolio
RNA targeting platform focused on genetic, cardiometabolic and central nervous system diseases
#Rare diseases
Whole-gene insertion technologies to enable a potential new class of genetic medicines
#Other
Focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity and cardiometabolic diseases
#Cardiometabolic